Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of quetiapine in healthy volunteers: association with pharmacokinetics, pharmacodynamics, and adverse effects.

International clinical psychopharmacology - 1 Mar 2015

Cabaleiro Teresa, López-Rodríguez Rosario, Román Manuel, Ochoa Dolores, Novalbos Jesús, Borobia Alberto, Carcas Antonio, Abad-Santos Francisco

Abstract excerpt

Quetiapine is an atypical antipsychotic used for treatment of schizophrenia. Variability in response to this drug may be associated with pharmacogenetics. The aim of this study was to identify genetic markers related to the pharmacokinetics, pharmacodynamics, and adverse effects of quetiapine. The study population comprised 79 healthy volunteers from two bioequivalence trials who were genotyped to identify...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensinogen
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP1A1

Share to Cytochrome P-450 CYP1A2

Share to Cytochrome P-450 CYP2C9

Share to Healthy Volunteers

Share to Prolactin

Share to Receptors, Dopamine D3

Source

Identifiers

PMID: 25025989
DOI: 10.1097/YIC.0000000000000047

Genes

AGT
DRD3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of quetiapine in healthy volunteers: association with pharmacokinetics, pharmacodynamics, and adverse effects.PMID 25025989Read ↗

Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects.Semantic proximity Read ↗

Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine PharmacokineticsSemantic proximity Read ↗

The Pharmacogenetics of Treatment with QuetiapineSemantic proximity Read ↗

Pharmacodynamic genetic variants related to antipsychotic adverse reactions in healthy volunteers.Semantic proximity Read ↗

Influence of ABCB1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of quetiapine in healthy volunteers.Semantic proximity Read ↗

MDR-1 genotypes and quetiapine pharmacokinetics in healthy volunteers.Semantic proximity Read ↗

Metabolic effects of aripiprazole and olanzapine multiple-dose treatment in healthy volunteers. Association with pharmacogeneticsSemantic proximity Read ↗

Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers.Semantic proximity Read ↗

Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics.Semantic proximity Read ↗

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.Semantic proximity Read ↗

The effect of CYP2D6 variation on antipsychotic-induced hyperprolactinaemia: a systematic review and meta-analysis.Semantic proximity Read ↗

Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.